Across TCGA pan-cancer cohorts, RNU6-262P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-262P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RNU6-262P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-262P is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

COAD, UCEC, and STAD are the cancer types where RNU6-262P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-262P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.162	.026	3	view →
UCEC	All	IV	−1.115	.001	2	view →
STAD	Male	All	+0.271	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-262P RNA expression & survival · all RNU6-262P data types